Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by TechTargeton Sep 30, 2015 2:00pm

80 Views

Post# 24149971

RE:RE:RE:RE:Update

It's called market sentiment. With the general market selloff and correction, I'm surprised the stock hasn't dropped.

There's a wall by traders at 18 cents as well.

It will take an accouncement of another win or licensing revenues bring back volume but as seen in the past, as volume goes up so does the SP.

Patience. Guys attending mid month don't buy on impulse. If the predicted Innovation Win at the show next month happens, that will also light up this stock.

If you are impatient, just fill the bids waiting! ;-)

Bullboard Posts

Visionstate set to leverage success in the U.S. market